Serum tumor growth factor-ß1 levels in patients with cirrhosis, chronic hepatitis B and chronic hepatitis C

Basit Öğe Kaydı
dc.contributor.authorKirmaz C.
dc.contributor.authorTerzioglu E.
dc.contributor.authorTopalak O.
dc.contributor.authorBayrak P.
dc.contributor.authorYilmaz O.
dc.contributor.authorErsoz G.
dc.contributor.authorSebik F.
dc.date.accessioned2019-10-27T00:22:36Z
dc.date.available2019-10-27T00:22:36Z
dc.date.issued2004
dc.departmentEge Üniversitesien_US
dc.description.abstractChronic liver disease and cirrhosis are two of the most important health problems according to current gastroenterology literature. Based on the recent developments in the field of immunology, advanced follow-up and treatment modalities have been introduced for these disorders. Immune defence against viral infections depends on effective cellular immune responses derived mainly from Th1-related cytokines. Th2 type immune responses can inhibit efficient immune function by secretion of several cytokines such as IL-10, TGF-ß1. In this particular study, we determined the serum levels of TGF-ß1, which plays a role in immune suppression and induction of tissue fibrosis. We evaluated the role of TGF-ß1 in the pathogenesis of chronic liver disease and cirrhosis. Fourteen chronic hepatitis B (CHB), 12 chronic hepatitis C (CHC) patients and 21 cirrhotic patients were enrolled in the study. The control group consisted of ten healthy people. Serum TGF-ß1 levels were higher in both cirrhosis and CHC group when compared to those in CHB and control groups (P < 0.05). Although serum TGF-ß1 levels in the cirrhosis group were higher than that in the CHC group, the difference was not statistically significant. In conclusion, elevated TGF-ß1 levels in patients with CHC and cirrhosis may have a role in the pathogenesis and chronicity of these diseases.en_US
dc.identifier.endpage116en_US
dc.identifier.issn1148-5493
dc.identifier.issue2en_US
dc.identifier.pmid15319169en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage112en_US
dc.identifier.urihttps://hdl.handle.net/11454/22617
dc.identifier.volume15en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.relation.ispartofEuropean Cytokine Networken_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectChronic hepatitis Ben_US
dc.subjectChronic hepatitis Cen_US
dc.subjectCirrhosisen_US
dc.subjectKnodell histology activity indexen_US
dc.subjectTGF-ß1en_US
dc.titleSerum tumor growth factor-ß1 levels in patients with cirrhosis, chronic hepatitis B and chronic hepatitis Cen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu